Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Investigation of novel ITPR1 variants in patients with late-onset ataxia

EF 2022-23

Résumé
In recent years, technological advances such as high-throughput sequencing have made it possible to elucidate the molecular mechanisms of many diseases. However, there are limitations to standard testing practices for more complex cases, such as the difficulty of interpreting variants. Therefore, many patients with a clinical diagnosis of a rare neurological disorder remain without a genetic diagnosis. These challenges are especially relevant in the research about ataxias, a group of rare neurological disorders usually affecting the cerebellum and resulting in balance and coordination problems. Over 60 subtypes of ataxias have been reported with significant clinical and genetic variability. Our hypothesis is that combining molecular genetics with functional genomics will enable us to better understand the underlying mechanisms of rare diseases, such as ataxias, in patients for whom traditional analyzes have not led to the identification of the genetic cause. We are currently investigating three novel DNA changes in ITPR1, an intracellular receptor important for calcium release. The determination of a pathologic impact is essential since these changes in the DNA sequence have not yet been shown to cause an ataxia. We are working on modeling the patients' DNA variations in a cellular model using the CRISPR-Cas9 genome editing technique. Using this model, we will characterize the effect of the variants on the receptor's function to enable us to confirm the diagnosis for these patients. Our project aims to improve our understanding of the mechanisms involved in ataxias, with the hope of offering genetic counselling for families and optimizing the medical management of patients. Ultimately, our research could lead to new therapeutic strategies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486006
Name
Legault-Cadieux Nab
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of novel ITPR1 variants in patients with late-onset ataxia
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ataxias; Cellular Models; Crispr-Cas9; Functional Validation; Genetics; Genome Editing; Neurosciences; Novel Variants; Rare Neurological Diseases
Abstract
In recent years, technological advances such as high-throughput sequencing have made it possible to elucidate the molecular mechanisms of many diseases. However, there are limitations to standard testing practices for more complex cases, such as the difficulty of interpreting variants. Therefore, many patients with a clinical diagnosis of a rare neurological disorder remain without a genetic diagnosis. These challenges are especially relevant in the research about ataxias, a group of rare neurological disorders usually affecting the cerebellum and resulting in balance and coordination problems. Over 60 subtypes of ataxias have been reported with significant clinical and genetic variability. Our hypothesis is that combining molecular genetics with functional genomics will enable us to better understand the underlying mechanisms of rare diseases, such as ataxias, in patients for whom traditional analyzes have not led to the identification of the genetic cause. We are currently investigating three novel DNA changes in ITPR1, an intracellular receptor important for calcium release. The determination of a pathologic impact is essential since these changes in the DNA sequence have not yet been shown to cause an ataxia. We are working on modeling the patients' DNA variations in a cellular model using the CRISPR-Cas9 genome editing technique. Using this model, we will characterize the effect of the variants on the receptor's function to enable us to confirm the diagnosis for these patients. Our project aims to improve our understanding of the mechanisms involved in ataxias, with the hope of offering genetic counselling for families and optimizing the medical management of patients. Ultimately, our research could lead to new therapeutic strategies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Legault-Cadieux, Nab
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~